evaluated the use of PET imaging to detect brain high-grade astrocytomas by targeting the SGLT2 with 18F-Me-4FDG in four patients diagnosed with WHO Grade III or IV astrocytomas [66]. The gene discussed is SLC5A2; the disease is astrocytoma (excluding glioblastoma).